after my own considerations remain clearly significant AND associated to Covid measures/vaccinations:
-- "..karditis" age 15-39 , increase 2020 to 2021
nearly all Vaccinated of this age group got their first&2nd jab till fall 2021;
I assume that heavier cases of ...carditis show up very soon after shot. So most of the increase should be caused by Covid vaccinations. In the absent of vaccination there occured no significant increase in 2020, showing that not Covid for itself caused "..karditis".
-- "M625- muscle atrophy" age 40+and 70+
I assume delayed effect of lockdown and/or vaccination.
If only lockdowns would have been the main reason, in year 2021 there would have been
expected a greater increase already. As it happened in 2022 actually.
-- "Diseases of the musculoskeletal system" age groups 15-69 :
a strong trend of decrease from 2016 to 2020 is followed by a increase from 2021 onwards.
Turning point can easily be assumed as of somewhere earlier in the year 2021.
-- strong increase of "Pneumonia" from 2019 to 2020 should be due to Covid infections and/or more sensitivity especially of respiratory llness suffering patients leading to more health care system visits and in consequence more diagnoses. But I guess more of the first cause.
-- increase of "Cough" als solely diagnosis is statisitically relevant, but in absolute numbers and from point of severity of illness not very important.
--LD032 / LD040 with clear significant increase from 2022 on,
similar to increase of
-- R570 /R571 , but both from 2023 on!
CANCER:
I see very high probability of increase 2022 at age 0-14 caused by vaccinations given to children from late 2021 onwards! --- very bad and sad.
from midth of 2022 onwards there were nearly no more jabs administered to children, so numbers of new cancer in children decreased in 2023.
Notably
age group 40-69 shows even in 2023 a lower cancer level as in prepandemic years!
maybe due to less visitations of health care system as established in general since start of pandemic, leading to less diagnosis?
maybe due to excess mortality concerning especially high vulnerable persons since 2020, that took away some first candidates for cancer, which therefor didnt became statistically ?
I think your analyses stress the importance to look not only at totals but also at different age classes; although this is tricky due to multiplicity problems.
The look at different age classes appears particularly important for “carditis”: Overall there was no clear trend, rather a continuation of a long-term increase. However, the age classes 0-14 and in particular 15-39 showed the issues that we C19 critics were afraid of for long. In contrast, the 70+ showed a long-term rise, maybe also the 40-69. Hence, there might be two deleterious factors: The C19 vaccines, evident in the younger, and cardiovascular medication (in general) in the elderly. For the latter I would think of antihypertensive medication, but we should also not forget statines and ezetemib, but maybe also recent antidiabetics. All these medications are virtually not given to those below 14, and rarely to those below 40, but to most above 70. Lumped together, we can no more or hardly identify the effect of the C19 vaccines on carditis on whole population level.
We should keep this in mind when interpreting the other figures and diagnoses. There might be a similar effect in cancer diagnoses. There is a plethora of data indicating that biopsies may trigger cancer or its spread. Biopsies are increasing with age; and nowadays also in woman in younger ages.
Striking are the figures for fever. This is the most typical sign (to be understood as in between signs and symptoms) for flu-like illness. It was certainly a very frequent immediate reaction of these vaccines. However, in 2022 these vaccines were far less frequently administered. Moreover, most data quite consistently indicate that booster (given since late 2021) caused less immediate reactions. This means that the sharp increases observed in 2022 are hardly to be interpreted as immediate reactions, but rather as long-term reactions to them, most likely as anyhow impairing infection defence. This assumption is further supported by the increases in coughing (“Husten”), pneumonia, and respiratory problems.
The effect of impaired infection defence should also be considered when interpreting increases in the various forms of “-itis” as well as cancer.
A bit surprising to me are the increases in “M” and in particularly in M625 (muscle wasting and atrophy). The latter most likely reflect the cases of “post vax”, which the mainstream prefers to label as “Long Covid”. Maybe other M diagnoses are related to this, but were less correctly differentiated. In turn, injuries to the musculoskeletal system might reflect the M- and M625-problems, but also the fractions, although they might also be explained by falls which were typically seen within the first 2 weeks of a vaccination.
after my own considerations remain clearly significant AND associated to Covid measures/vaccinations:
-- "..karditis" age 15-39 , increase 2020 to 2021
nearly all Vaccinated of this age group got their first&2nd jab till fall 2021;
I assume that heavier cases of ...carditis show up very soon after shot. So most of the increase should be caused by Covid vaccinations. In the absent of vaccination there occured no significant increase in 2020, showing that not Covid for itself caused "..karditis".
-- "M625- muscle atrophy" age 40+and 70+
I assume delayed effect of lockdown and/or vaccination.
If only lockdowns would have been the main reason, in year 2021 there would have been
expected a greater increase already. As it happened in 2022 actually.
-- "Diseases of the musculoskeletal system" age groups 15-69 :
a strong trend of decrease from 2016 to 2020 is followed by a increase from 2021 onwards.
Turning point can easily be assumed as of somewhere earlier in the year 2021.
-- strong increase of "Pneumonia" from 2019 to 2020 should be due to Covid infections and/or more sensitivity especially of respiratory llness suffering patients leading to more health care system visits and in consequence more diagnoses. But I guess more of the first cause.
-- increase of "Cough" als solely diagnosis is statisitically relevant, but in absolute numbers and from point of severity of illness not very important.
--LD032 / LD040 with clear significant increase from 2022 on,
similar to increase of
-- R570 /R571 , but both from 2023 on!
CANCER:
I see very high probability of increase 2022 at age 0-14 caused by vaccinations given to children from late 2021 onwards! --- very bad and sad.
from midth of 2022 onwards there were nearly no more jabs administered to children, so numbers of new cancer in children decreased in 2023.
Notably
age group 40-69 shows even in 2023 a lower cancer level as in prepandemic years!
maybe due to less visitations of health care system as established in general since start of pandemic, leading to less diagnosis?
maybe due to excess mortality concerning especially high vulnerable persons since 2020, that took away some first candidates for cancer, which therefor didnt became statistically ?
Thank you very much, excellent analysis!
I think your analyses stress the importance to look not only at totals but also at different age classes; although this is tricky due to multiplicity problems.
The look at different age classes appears particularly important for “carditis”: Overall there was no clear trend, rather a continuation of a long-term increase. However, the age classes 0-14 and in particular 15-39 showed the issues that we C19 critics were afraid of for long. In contrast, the 70+ showed a long-term rise, maybe also the 40-69. Hence, there might be two deleterious factors: The C19 vaccines, evident in the younger, and cardiovascular medication (in general) in the elderly. For the latter I would think of antihypertensive medication, but we should also not forget statines and ezetemib, but maybe also recent antidiabetics. All these medications are virtually not given to those below 14, and rarely to those below 40, but to most above 70. Lumped together, we can no more or hardly identify the effect of the C19 vaccines on carditis on whole population level.
We should keep this in mind when interpreting the other figures and diagnoses. There might be a similar effect in cancer diagnoses. There is a plethora of data indicating that biopsies may trigger cancer or its spread. Biopsies are increasing with age; and nowadays also in woman in younger ages.
Striking are the figures for fever. This is the most typical sign (to be understood as in between signs and symptoms) for flu-like illness. It was certainly a very frequent immediate reaction of these vaccines. However, in 2022 these vaccines were far less frequently administered. Moreover, most data quite consistently indicate that booster (given since late 2021) caused less immediate reactions. This means that the sharp increases observed in 2022 are hardly to be interpreted as immediate reactions, but rather as long-term reactions to them, most likely as anyhow impairing infection defence. This assumption is further supported by the increases in coughing (“Husten”), pneumonia, and respiratory problems.
The effect of impaired infection defence should also be considered when interpreting increases in the various forms of “-itis” as well as cancer.
A bit surprising to me are the increases in “M” and in particularly in M625 (muscle wasting and atrophy). The latter most likely reflect the cases of “post vax”, which the mainstream prefers to label as “Long Covid”. Maybe other M diagnoses are related to this, but were less correctly differentiated. In turn, injuries to the musculoskeletal system might reflect the M- and M625-problems, but also the fractions, although they might also be explained by falls which were typically seen within the first 2 weeks of a vaccination.